1-8 of 8
Scott F Huntington, MDMPH
Close
Sort by
Journal Articles

Does Provider Experience Treating Patients (pts) with Myelodysplastic Syndromes (MDS) Explain Duration of Hypomethylating Agent (HMA) Therapy and Overall Survival (OS)? A Large Population-Based Analysis

Amer M. Zeidan, MBBS, MHS, Xin Hu, MS, Weiwei Zhu, MPH, Maximilian Stahl, MD, Smith Giri, MBBS, Scott F Huntington, MDMPH, Rong Wang, PhD, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, MD PhD, Amy J. Davidoff, PhD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 370.
https://doi.org/10.1182/blood-2018-99-111052
Published: 2018
Journal Articles

Transfusion Independence in Lower-Risk, Non-del5(q) Myelodysplastic Syndromes (LR-MDS) Among Patients (pts) Initiating Hypomethylating Agents (HMAs) While Receiving Red Blood Cell (RBC) Transfusions

Amer M. Zeidan, MBBS, MHS, Weiwei Zhu, MPH, Rong Wang, PhD, Maximilian Stahl, MD, Scott F Huntington, MDMPH, Smith Giri, MBBS, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, MD PhD, Amy J. Davidoff, PhD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 838.
https://doi.org/10.1182/blood-2018-99-116497
Published: 2018
Journal Articles

Racial Disparities in the Utilization of Recommended Supportive Care Among Patients with Multiple Myeloma in the United States

Smith Giri, MBBS, Weiwei Zhu, MPH, Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Xiaomei Ma, PhD, Amy J. Davidoff, PhD MS, Scott F Huntington, MDMPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 978.
https://doi.org/10.1182/blood-2018-99-119791
Published: 2018
Journal Articles

Evaluating the Economic Burden and Health Care Utilization Following First-Line Therapy for Diffuse Large B-Cell Lymphoma Patients in the US Medicare Population

Scott F Huntington, MDMPH, Allison Keshishian, MPH, Lin Xie, MA, MS, Onur Baser, MS, PhD, Michael McGuire, PharmD
Journal: Blood
Blood (2016) 128 (22): 3574.
https://doi.org/10.1182/blood.V128.22.3574.3574
Published: 2016
Journal Articles

Hypomethylating Agent Therapy and Survival Among Older Patients with Chronic Myelomonocytic Leukemia in the United States: A Large Population-Based Study

Amer M. Zeidan, MBBS, MHS, Xin Hu, Jessica B. Long, PhD, Rong Wang, PhD, Scott F Huntington, MDMPH, Nikolai A Podoltsev, MD PhD, Steven Gore, Xiaomei Ma, PhD, Amy J. Davidoff, PhD
Journal: Blood
Blood (2016) 128 (22): 394.
https://doi.org/10.1182/blood.V128.22.394.394
Published: 2016
Journal Articles

Comparative Effectiveness of Azacitidine Versus Decitabine Among Older Adults Diagnosed with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

Amer M. Zeidan, MBBS, MHS, Jessica B. Long, PhD, Jane Hall, Rong Wang, PhD, Scott F Huntington, MDMPH, Gregory Abel, MD MPH, Thomas Prebet, MD, Nikolai A. Podoltsev, MDPhD, Cary P. Gross, MD, Steven D. Gore, MD, Xiaomei Ma, PhD, Amy J. Davidoff, PhD
Journal: Blood
Blood (2015) 126 (23): 3285.
https://doi.org/10.1182/blood.V126.23.3285.3285
Published: 2015
Journal Articles

Lack of Association Between Costs of Care and Overall Survival (OS) Among Medicare Beneficiaries with Myelodysplastic Syndromes (MDS) in the United States (US)

Amer M. Zeidan, MBBS, MHS, Rong Wang, PhD, Amy J. Davidoff, PhD, Steven D. Gore, MD, Pamela R Soulos, MPH, Scott F Huntington, MDMPH, Cary P. Gross, MD, Xiaomei Ma, PhD
Journal: Blood
Blood (2015) 126 (23): 873.
https://doi.org/10.1182/blood.V126.23.873.873
Published: 2015
Journal Articles

The Impact of Marital and Socioeconomic Status on Outcomes of Patients with Acute Promyelocytic Leukemia

Scott F Huntington, MDMPH, Nirav N. Shah, MD, Andrew Epstein, PhD MPP, Alison W. Loren, MD
Journal: Blood
Blood (2014) 124 (21): 1282.
https://doi.org/10.1182/blood.V124.21.1282.1282
Published: 2014